TMEM56 deficiency impairs the haem metabolism and cell cycle progression during human erythropoiesis
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19801 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Jingwei Wang und 21 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Erythropoiesis, Membrane Proteins, Cell Cycle, Heme. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, The CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
TMEM56 , a gene coding a transmembrane protein, is abundantly expressed in erythroid cells. Despite this, its role in erythropoiesis has not been well characterized. In this study, we sought to clarify the function of TMEM56 in erythroid development, focusing specifically on its involvement in haem biosynthesis and cell cycle progression. To do this, we used CD34 + haematopoietic stem cells derived from umbilical cord blood and differentiated them into erythroid cells in an ex vivo model. Our results indicate that the loss of TMEM56 disrupts haem biosynthesis and impairs erythroid differentiation. Furthermore, deletion of Tmem56 in the erythroid lineage in murine models using erythropoietin receptor (EpoR)‐Cre revealed defects in erythroid progenitors within the bone marrow under both normal conditions and during haemolytic anaemia. These observations underscore the regulatory role of TMEM56 in maintaining erythroid lineage homeostasis. Taken together, our results unveil a previously unrecognized function of TMEM56 in erythroid differentiation and suggest its potential as an unfounded target for therapeutic strategies in the treatment of erythropoietic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- Tianjin Institutes of Health Science, Tianjin, China.
ORCID-Profile: Lingyue Zheng, Lihong Shi
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- The CAMS Innovation Fund for Medical Sciences
- The Haihe Laboratory of Cell Ecosystem Innovation Fund
- Tianjin Municipal Science and Technology Commission Grant
Zitieren
APA
Wang, J., Zhang, Y., Liu, J., Wu, J., Liang, Y., Xu, C., Ma, J., Liang, J., Zhao, Y., Zhang, X., Li, Y., Wang, D., Zheng, L., Wang, D., Jin, X., Song, H., Zhu, X., Cheng, Q., Lin, L., …, & Shi, L. (2024). TMEM56 deficiency impairs the haem metabolism and cell cycle progression during human erythropoiesis. British Journal of Haematology. https://doi.org/10.1111/bjh.19801
Vancouver
Wang J, Zhang Y, Liu J, Wu J, Liang Y, Xu C, et al. TMEM56 deficiency impairs the haem metabolism and cell cycle progression during human erythropoiesis. British Journal of Haematology. 2024. doi:10.1111/bjh.19801
BibTeX
@article{Wang2024,
author = {Wang, Jingwei and Zhang, Yingnan and Liu, Jinhua and Wu, Jing and Liang, Yipeng and Xu, Changlu and Ma, Jinfa and Liang, Jing and Zhao, Yanhong and Zhang, Xiaoru and Li, Yue and Wang, Di and Zheng, Lingyue and Wang, Ding and Jin, Xu and Song, Haoze and Zhu, Xu and Cheng, Qimei and Lin, Lexuan and Gao, Jie and Tong, Jingyuan and Shi, Lihong},
title = {TMEM56 deficiency impairs the haem metabolism and cell cycle progression during human erythropoiesis},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19801}
}
EUVIMED